A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
Clinical trial NCT00631150 · COMPLETED
Trial details
- NCT number
- NCT00631150
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2004-07-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.